Screening for diabetic peripheral neuropathy in resource-limited settings
Abstract Background Diabetic neuropathy is the most common microvascular complication of diabetes mellitus and a major risk factor for diabetes-related lower-extremity complications. Diffuse neuropathy is the most frequently encountered pattern of neurological dysfunction and presents clinically as...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-03-01
|
| Series: | Diabetology & Metabolic Syndrome |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13098-023-01032-x |
| _version_ | 1797864019509379072 |
|---|---|
| author | Ken Munene Nkonge Dennis Karani Nkonge Teresa Njeri Nkonge |
| author_facet | Ken Munene Nkonge Dennis Karani Nkonge Teresa Njeri Nkonge |
| author_sort | Ken Munene Nkonge |
| collection | DOAJ |
| description | Abstract Background Diabetic neuropathy is the most common microvascular complication of diabetes mellitus and a major risk factor for diabetes-related lower-extremity complications. Diffuse neuropathy is the most frequently encountered pattern of neurological dysfunction and presents clinically as distal symmetrical sensorimotor polyneuropathy. Due to the increasing public health significance of diabetes mellitus and its complications, screening for diabetic peripheral neuropathy is essential. Consequently, a review of the principles that guide screening practices, especially in resource-limited clinical settings, is urgently needed. Main body Numerous evidence-based assessments are used to detect diabetic peripheral neuropathy. In accordance with current guideline recommendations from the American Diabetes Association, International Diabetes Federation, International Working Group on the Diabetic Foot, and National Institute for Health and Care Excellence, a screening algorithm for diabetic peripheral neuropathy based on multiphasic clinical assessment, stratification according to risk of developing diabetic foot syndrome, individualized treatment, and scheduled follow-up is suggested for use in resource-limited settings. Conclusions Screening for diabetic peripheral neuropathy in resource-limited settings requires a practical and comprehensive approach in order to promptly identify affected individuals. The principles of screening for diabetic peripheral neuropathy are: multiphasic approach, risk stratification, individualized treatment, and scheduled follow-up. Regular screening for diabetes-related foot disease using simple clinical assessments may improve patient outcomes. |
| first_indexed | 2024-04-09T22:44:52Z |
| format | Article |
| id | doaj.art-6cc0051fc2e34e98ac9a8ca3daf8f1a9 |
| institution | Directory Open Access Journal |
| issn | 1758-5996 |
| language | English |
| last_indexed | 2024-04-09T22:44:52Z |
| publishDate | 2023-03-01 |
| publisher | BMC |
| record_format | Article |
| series | Diabetology & Metabolic Syndrome |
| spelling | doaj.art-6cc0051fc2e34e98ac9a8ca3daf8f1a92023-03-22T11:55:42ZengBMCDiabetology & Metabolic Syndrome1758-59962023-03-0115111110.1186/s13098-023-01032-xScreening for diabetic peripheral neuropathy in resource-limited settingsKen Munene Nkonge0Dennis Karani Nkonge1Teresa Njeri Nkonge2University of NairobiUniversity of NairobiMcMaster UniversityAbstract Background Diabetic neuropathy is the most common microvascular complication of diabetes mellitus and a major risk factor for diabetes-related lower-extremity complications. Diffuse neuropathy is the most frequently encountered pattern of neurological dysfunction and presents clinically as distal symmetrical sensorimotor polyneuropathy. Due to the increasing public health significance of diabetes mellitus and its complications, screening for diabetic peripheral neuropathy is essential. Consequently, a review of the principles that guide screening practices, especially in resource-limited clinical settings, is urgently needed. Main body Numerous evidence-based assessments are used to detect diabetic peripheral neuropathy. In accordance with current guideline recommendations from the American Diabetes Association, International Diabetes Federation, International Working Group on the Diabetic Foot, and National Institute for Health and Care Excellence, a screening algorithm for diabetic peripheral neuropathy based on multiphasic clinical assessment, stratification according to risk of developing diabetic foot syndrome, individualized treatment, and scheduled follow-up is suggested for use in resource-limited settings. Conclusions Screening for diabetic peripheral neuropathy in resource-limited settings requires a practical and comprehensive approach in order to promptly identify affected individuals. The principles of screening for diabetic peripheral neuropathy are: multiphasic approach, risk stratification, individualized treatment, and scheduled follow-up. Regular screening for diabetes-related foot disease using simple clinical assessments may improve patient outcomes.https://doi.org/10.1186/s13098-023-01032-xDiabetesDiabetic foot syndromeDiabetic peripheral neuropathyMichigan neuropathy screening instrumentNeuropadRisk factors |
| spellingShingle | Ken Munene Nkonge Dennis Karani Nkonge Teresa Njeri Nkonge Screening for diabetic peripheral neuropathy in resource-limited settings Diabetology & Metabolic Syndrome Diabetes Diabetic foot syndrome Diabetic peripheral neuropathy Michigan neuropathy screening instrument Neuropad Risk factors |
| title | Screening for diabetic peripheral neuropathy in resource-limited settings |
| title_full | Screening for diabetic peripheral neuropathy in resource-limited settings |
| title_fullStr | Screening for diabetic peripheral neuropathy in resource-limited settings |
| title_full_unstemmed | Screening for diabetic peripheral neuropathy in resource-limited settings |
| title_short | Screening for diabetic peripheral neuropathy in resource-limited settings |
| title_sort | screening for diabetic peripheral neuropathy in resource limited settings |
| topic | Diabetes Diabetic foot syndrome Diabetic peripheral neuropathy Michigan neuropathy screening instrument Neuropad Risk factors |
| url | https://doi.org/10.1186/s13098-023-01032-x |
| work_keys_str_mv | AT kenmunenenkonge screeningfordiabeticperipheralneuropathyinresourcelimitedsettings AT denniskaraninkonge screeningfordiabeticperipheralneuropathyinresourcelimitedsettings AT teresanjerinkonge screeningfordiabeticperipheralneuropathyinresourcelimitedsettings |